Home
/ Spexis
/ Competitors

Spexis Competitors and Similar CompaniesClear all

Spexis's competitors and similar companies include XL-protein, LimmaTech Biologics, Vita Therapeutics and Tiburio Therapeutics.

	Spexis Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.	XL-protein XL-protein is a company that develops and commercializes its proprietary PASylation technology to extend the plasma half-life of biopharmaceuticals.	LimmaTech Biologics LimmaTech Biologics is a biopharmaceutical company focused on the development and manufacture of pharmaceuticals.	Vita Therapeutics Vita Therapeutics is a cell engineering company harnessing the power of genetics to develop cellular therapies.	Tiburio Therapeutics Tiburio Therapeutics is a biopharmaceutical company.
Founding Date	Founding Date 1996	Founding Date 2009	Founding Date 2015	Founding Date 2018	Founding Date 2018
Type	Type Public	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering biotech drug development pharma
Locations	Locations Allschwil, CH HQ	Locations Freising, DE HQ	Locations Schlieren, CH HQ	Locations Baltimore, US HQ	Locations Cambridge, US HQ
Employees	Employees 50	Employees 5	Employees 53	Employees 9	Employees 722% decrease
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 32m (almost 5 years ago)	Latest funding round $ 31m (over 7 years ago)
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 32m	Total funding raised $ 31m